Note: Live price is not available for this stock. Showing closing price. For historical calculations, prices are adjusted for splits, bonus and rights issue. Percentage change shown is absolute irrespective of the period.
ERIS Stock Analysis
Views
Red Flags
Positive
Strong price momentum
High and improving operating margin
Strong revenue growth and above median growth of industry
Moderate EPS growth and above median growth of industry
Low Debt to Equity, not much change from last year
Company's earnings are of high quality
Negative
Expensive and at a premium to industry median P/E
Analysts have been downgrading forward EPS estimates
Low dividend yield
Neutral
Moderate and stable ROE
No red flags found!
No significant red flags found in the stock.
Snapshot
See detailed analysis
ERIS Shareholding Pattern
An overview of who owns the company. Click on chart icon to view historical movement.
ERIS Bulk, Block & Insider Trades
ERIS Dividends, Splits & Bonus
Dividend Events
Capital Change Events
Others
Share Buyback"On Market Tender Offer. Total Amount Returned INR 999999750. Share Capital 1.26 percent currently. As of 03 July 2019Shares repurchased 1739130." Ex-date: 12th Jul 2019 Announced on: 3rd Jul 2019
Company Profile
Eris Lifesciences Limited is an India-based pharmaceutical company. The Company is engaged in the manufacture and marketing of pharmaceutical products. The Company has a presence in major therapies like oral anti-diabetes, insulins, cardiovascular, vitamins/minerals and dermatology. Its flagship the... Read More
Key personnel
Mr. Amit Indubhushan BakshiD
Executive Chairman of the Board, Managing Director
Mr. Sachin Shah
Chief Financial Officer
Mr. Krishnakumar VaidyanathanD
Chief Operating Officer, Executive Director
Mr. Milind Talegaonkar
Compliance Officer, Company Secretary
Mr. Inderjeet Singh NegiD
Executive Director
Mr. Kaushal Kamleshkumar ShahD
Executive Director
Mr. Prashant GuptaD
Non-Executive Independent Director
Ms. Kalpana UnadkatD
Non-Executive Independent Director
View all
Incorporated on
Last Annual
Last Interim
No. of Employees
IPO date
Free Float
Website
Phone no.
Address
Frequently asked questions
What is the current share price of Eris Lifesciences Ltd.?
The current share price of Eris Lifesciences Ltd. is ₹ 1,506.95 as of 09 Jan 2026.
What is the PE ratio of Eris Lifesciences Ltd.?
The Price-to-Earnings (PE) ratio of Eris Lifesciences Ltd. is 49.43 as of the latest financial data.
What is the ROE and ROCE of Eris Lifesciences Ltd.?
Eris Lifesciences Ltd. has a Return on Equity (ROE) of 14.17% and a Return on Capital Employed (ROCE) of 13.03% as per the latest financial reports.
What is the market cap of Eris Lifesciences Ltd.?
The market capitalization of Eris Lifesciences Ltd. stands at ₹ 20,527.20 Cr.
What is the dividend yield of Eris Lifesciences Ltd.?
The dividend yield of Eris Lifesciences Ltd. is 0.49% based on the current market price.
What is the RSI of Eris Lifesciences Ltd.?
The Relative Strength Index (RSI) of Eris Lifesciences Ltd. is 40.61.
What is the FII and DII holding in Eris Lifesciences Ltd.?
Foreign Institutional Investors (FII) hold 7.21% and Domestic Institutional Investors (DII) hold 18.53% of Eris Lifesciences Ltd. shares.
What sector does Eris Lifesciences Ltd. belong to?
Eris Lifesciences Ltd. operates in the Healthcare sector.
What is the beta of Eris Lifesciences Ltd. stock?
The beta of Eris Lifesciences Ltd. stock is 0.52, indicating its volatility relative to the broader market.
